WST
WEST PHARMACEUTICAL SERVICES INC
$311.13
+1.84%
$21.6B
No data for this timeframe.
Vol
Market Cap$21.6B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (83%)
Inst. Holders10 funds
Inst. Value$3.7B
Inst. Activity4 buys / 0 sells
Insider Activity0B / 2S
Insider Net $-$1.1M
SEC Reports9
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. PA·CIK 0000105770·Prev Close $305.50
Recent Activity
May 11, 2026
SEC
West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfiltration and system en
8-K — Impact 7/10
May 6, 2026
SEC
Two officers sold a total of $1.13M in stock post-strong Q1 earnings; nine directors received non-cash stock grants. Sal
CLUSTER — Impact 2/10
May 6, 2026
SEC
Insider cluster at West Pharmaceutical Services shows $1.13M in open-market sales by two non-C-suite executives shortly
CLUSTER — Impact 2/10
May 4, 2026
Insider
BUTHMAN MARK A sold 791 shares
Director @ $0.00 ($0.00)
May 4, 2026
Insider
Feehery William F sold 791 shares
Director @ $0.00 ($0.00)
May 4, 2026
Insider
FRIEL ROBERT F sold 791 shares
Director @ $0.00 ($0.00)
Inst.
NORGES BANK — NEW
988,737 shares ($272.0M)
Inst.
TWO SIGMA INVESTMENTS, LP — ADD
139,939 shares ($38.5M)
Price Targets
$349.85
+12.4% upside
Buy
Current $311.13
Low $310.00
Median $350.00
High $400.00
13 analysts
$310.00
$400.00
Analyst Ratings
6Strong Buy
13Buy
4Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 27, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Apr 14, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Feb 13, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| Feb 3, 2026 | Evercore ISI Group | MAINTAIN | Outperform → Outperform |
| Dec 2, 2025 | Morgan Stanley | INITIATE | Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $2.08 ▲ +4.5% | $2.05 — $2.12 | 13% YoY | 11 |
| Next Q | $2.13 ▲ +1.6% | $2.10 — $2.17 | 9% YoY | 11 |
| Current FY | $8.62 ▲ +7.6% | $8.50 — $8.82 | 18% YoY | 15 |
| Next FY | $9.55 ▲ +7.7% | $9.07 — $10.28 | 11% YoY | 15 |
Latest Reports
BEARISH
8-K
7/10
West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfiltration and system en
May 11, 2026
NEUTRAL
CLUSTER
2/10
Two officers sold a total of $1.13M in stock post-strong Q1 earnings; nine directors received non-cash stock grants. Sal
May 6, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $2.6B | — |
| MORGAN STANLEY | $421.5M | ADD |
| NORGES BANK | $272.0M | NEW |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $149.3M | NEW |
| BANK OF AMERICA CORP | $146.3M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 4, 2026 | BUTHMAN MARK | A | $0.00 |
| May 4, 2026 | Feehery William | A | $0.00 |
| May 4, 2026 | FRIEL ROBERT | A | $0.00 |
| May 4, 2026 | HAUGEN JANET | A | $0.00 |
| May 4, 2026 | Joseph Molly | A | $0.00 |
10 institutional holders with $3.7B total value (13,604,363 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, NORGES. Net buying activity: 4 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 9,539,173 | $2.6B | 70.1% | — |
| 2 | MORGAN STANLEY | 1,531,858 | $421.5M | 11.3% | ADD +45.0% |
| 3 | NORGES BANK | 988,737 | $272.0M | 7.3% | NEW |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 542,803 | $149.3M | 4.0% | NEW |
| 5 | BANK OF AMERICA CORP /DE/ | 531,846 | $146.3M | 3.9% | — |
| 6 | TWO SIGMA INVESTMENTS, LP | 139,939 | $38.5M | 1.0% | ADD +38.3% |
| 7 | FMR LLC | 109,654 | $30.2M | 0.8% | DOUBLED +147.2% |
| 8 | WELLS FARGO & COMPANY/MN | 106,711 | $29.4M | 0.8% | ADD +26.7% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 104,736 | $28.8M | 0.8% | NEW |
| 10 | Hillman Capital Management, Inc. | 8,906 | $2.5M | 0.1% | NEW |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 988,737 | — | $272.0M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 101,201 | 139,939 | +38.3% | $38.5M | 2025-Q4 |
| FMR LLC | DOUBLED | 44,364 | 109,654 | +147.2% | $30.2M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 104,736 | — | $28.8M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 584,065 | 101,201 | -82.7% | $26.5M | 2025-Q3 |
| FMR LLC | TRIM | 104,784 | 44,364 | -57.7% | $11.6M | 2025-Q3 |
| Hillman Capital Management, Inc. | NEW | — | 10,273 | — | $2.7M | 2025-Q3 |
| NORGES BANK | EXIT | 917,792 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 24,300 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 917,792 | — | $200.8M | 2025-Q2 |
| UBS Group AG | ADD | 182,237 | 299,118 | +64.1% | $65.4M | 2025-Q2 |
| FMR LLC | NEAR_EXIT | 738,949 | 104,784 | -85.8% | $22.9M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 24,300 | — | $5.3M | 2025-Q2 |
| FMR LLC | TRIM | 1,090,603 | 738,949 | -32.2% | $165.4M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 75,988 | 522,827 | +588.0% | $117.1M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 735,778 | 398,827 | -45.8% | $89.3M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | ADD | 93,393 | 118,298 | +26.7% | $26.5M | 2025-Q1 |
| NORGES BANK | EXIT | 887,177 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 140,826 | 735,778 | +422.5% | $241.0M | 2024-Q4 |
| UBS Group AG | ADD | 119,081 | 151,439 | +27.2% | $49.6M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 128,860 | 93,393 | -27.5% | $30.6M | 2024-Q4 |
| MORGAN STANLEY | ADD | 670,036 | 971,485 | +45.0% | $291.6M | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 448,184 | — | $134.5M | 2024-Q3 |
18 unique insiders with 2 transactions. Net insider value: -$1.1M ($0.00 bought, $1.1M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 4, 2026 | BUTHMAN MARK A | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | Feehery William F | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | FRIEL ROBERT F | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | HAUGEN JANET BRUTSCHEA | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | Joseph Molly | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | Keller Deborah L | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | Pucci Paolo | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | LAI GOLDMAN MYLA | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | Lockhart Stephen H | Director | A | 791 | $0.00 | $0.00 |
| May 4, 2026 | Michels Douglas A | Director | A | 791 | $0.00 | $0.00 |
| Apr 27, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | M | 2,817 | $83.47 | $235.1K |
| Apr 27, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | SELL | 2,817 | $305.20 | $859.8K |
| Apr 27, 2026 | Winters Chad | VP, Chief Accounting Officer | M | 896 | $173.22 | $155.2K |
| Apr 27, 2026 | Winters Chad | VP, Chief Accounting Officer | SELL | 896 | $300.67 | $269.4K |
| Apr 27, 2026 | Winters Chad | VP, Chief Accounting Officer | M | 896 | $0.00 | $0.00 |
| Apr 27, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | M | 2,817 | $0.00 | $0.00 |
| Mar 31, 2026 | HAUGEN JANET BRUTSCHEA | Director | A | 52 | $250.64 | $13.0K |
| Mar 1, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | A | 1,131 | $0.00 | $0.00 |
| Mar 1, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | A | 2,691 | $0.00 | $0.00 |
| Mar 1, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | A | 3,082 | $0.00 | $0.00 |
| Mar 1, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | A | 7,337 | $0.00 | $0.00 |
| Mar 1, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | A | 437 | $0.00 | $0.00 |
| Mar 1, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | A | 1,040 | $0.00 | $0.00 |
| Mar 1, 2026 | Winters Chad | VP, Chief Accounting Officer | A | 340 | $0.00 | $0.00 |
| Mar 1, 2026 | Winters Chad | VP, Chief Accounting Officer | A | 808 | $0.00 | $0.00 |
| Mar 1, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | A | 1,712 | $0.00 | $0.00 |
| Mar 1, 2026 | Finch Norman D. Jr. | SVP, GC & Corporate Secretary | A | 1,285 | $0.00 | $0.00 |
| Mar 1, 2026 | Finch Norman D. Jr. | SVP, GC & Corporate Secretary | A | 3,057 | $0.00 | $0.00 |
| Mar 1, 2026 | Green Eric Mark | President, CEO and Board Chair | A | 6,986 | $0.00 | $0.00 |
| Mar 1, 2026 | Green Eric Mark | President, CEO and Board Chair | A | 16,630 | $0.00 | $0.00 |
| Mar 1, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | A | 720 | $0.00 | $0.00 |
| Feb 20, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | M | 383.382 | $0.00 | $0.00 |
| Feb 20, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | M | 383.382 | $0.00 | $0.00 |
| Feb 20, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | F | 129.545 | $241.12 | $31.2K |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | M | 60.22 | $0.00 | $0.00 |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | F | 22.069 | $241.12 | $5.3K |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | M | 60.22 | $0.00 | $0.00 |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | M | 89.328 | $0.00 | $0.00 |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | M | 89.328 | $0.00 | $0.00 |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | F | 30.184 | $241.12 | $7.3K |
| Feb 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | M | 4,230.525 | $0.00 | $0.00 |
| Feb 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | F | 1,250.034 | $246.16 | $307.7K |
| Feb 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | M | 4,230.525 | $0.00 | $0.00 |
9 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 7 neutral. Avg impact: 3.2/10.
BEARISH
8-K
7/10
West Pharmaceutical (WST) disclosed a material cybersecurity attack on May 7, 2026, with data exfilt
May 11, 2026
NEUTRAL
CLUSTER
2/10
Two officers sold a total of $1.13M in stock post-strong Q1 earnings; nine directors received non-ca
May 6, 2026
NEUTRAL
CLUSTER
2/10
Insider cluster at West Pharmaceutical Services shows $1.13M in open-market sales by two non-C-suite
May 6, 2026
NEUTRAL
CLUSTER
2/10
Two insiders at West Pharmaceutical Services sold a total of $1.13M in shares, representing a trivia
May 6, 2026
NEUTRAL
CLUSTER
2/10
Insider cluster at West Pharmaceutical Services includes two small open-market sales ($1.13M total)
May 6, 2026
NEUTRAL
CLUSTER
2/10
Two insiders sold $1.13M worth of WST shares (0.005% of market cap) following strong Q1 earnings. Th
May 6, 2026
NEUTRAL
CLUSTER
2/10
Two WST insiders (Sr. VP HR and VP/CAO) sold a combined $1.13M in open-market shares on April 27, 20
Apr 29, 2026
BULLISH
8-K
8/10
West Pharmaceutical Services reported strong Q1 2026 results with revenue of $844.9M (+21.0% YoY) an
Apr 23, 2026
NEUTRAL
DEFA14A
2/10
Analysis based on filing metadata only — document content was unavailable
Mar 12, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (83% buy). Based on 23 analysts: 6 strong buy, 13 buy, 4 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$349.85 mean target
+12.4% upside
Buy (1.53)
$310.00 Low
$400.00 High
| Metric | Value |
|---|---|
| Current Price | $311.13 |
| Target Low | $310.00 |
| Target Mean | $349.85 |
| Target Median | $350.00 |
| Target High | $400.00 |
| # Analysts | 13 |
| Recommendation | Buy (1.53) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$2.08 | $2.05 | $2.12 | 13.3% | +4.5% | 11↑ 0↓ | $0.8B | 9.5% | 11 |
| Next Q 2026-09-30 |
$2.13 | $2.10 | $2.17 | 8.7% | +1.6% | 9↑ 2↓ | $0.8B | 1.2% | 11 |
| Current FY 2026-12-31 |
$8.62 | $8.50 | $8.82 | 18.3% | +7.6% | 15↑ 0↓ | $3.3B | 8.4% | 15 |
| Next FY 2027-12-31 |
$9.55 | $9.07 | $10.28 | 10.8% | +7.7% | 15↑ 0↓ | $3.5B | 6.2% | 15 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $2.084 | |
| 7d ago | $2.084 | |
| 30d ago | $1.994 | +0.089 |
| 60d ago | $1.992 | +0.092 |
| 90d ago | $1.946 | +0.138 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 27, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 14, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 13, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 3, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Dec 2, 2025 | Morgan Stanley | INITIATE | — | Equal-Weight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 6 | 13 | 4 | 0 | 0 | 83% | |
| Apr 1, 2026 | 6 | 12 | 5 | 0 | 0 | 78% | |
| Mar 1, 2026 | 6 | 12 | 5 | 0 | 0 | 78% | |
| Feb 1, 2026 | 6 | 12 | 5 | 0 | 0 | 78% | |
| Jan 1, 2026 | 6 | 11 | 5 | 0 | 0 | 77% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 7, 2026
short_volume
Short Volume: WST — 65.5% short (0.4M / 0.5M)
Short: 353,144 | Exempt: 79 | TRF Vol: 538,798 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
dark_pool
Dark Pool: WST — 1.5M shares, 48,037 trades
Week starting 2026-04-27. Total ATS volume: 1,524,375 shares across 48,037 trades.
Apr 23, 2026
earnings_calendar
WST Q1 2026 Earnings Before Market Open — 2026-04-23
Apr 20, 2026
dark_pool
Dark Pool: WST — 2.4M shares, 64,592 trades
Week starting 2026-04-20. Total ATS volume: 2,445,953 shares across 64,592 trades.
Apr 13, 2026
dark_pool
Dark Pool: WST — 1.1M shares, 38,605 trades
Week starting 2026-04-13. Total ATS volume: 1,127,417 shares across 38,605 trades.
Apr 6, 2026
dark_pool
Dark Pool: WST — 1.0M shares, 38,267 trades
Week starting 2026-04-06. Total ATS volume: 1,029,729 shares across 38,267 trades.
Mar 30, 2026
dark_pool
Dark Pool: WST — 1.0M shares, 32,660 trades
Week starting 2026-03-30. Total ATS volume: 1,016,881 shares across 32,660 trades.
Mar 23, 2026
dark_pool
Dark Pool: WST — 1.3M shares, 39,279 trades
Week starting 2026-03-23. Total ATS volume: 1,293,992 shares across 39,279 trades.
Mar 16, 2026
dark_pool
Dark Pool: WST — 1.2M shares, 40,812 trades
Week starting 2026-03-16. Total ATS volume: 1,177,100 shares across 40,812 trades.
Mar 9, 2026
dark_pool
Dark Pool: WST — 1.3M shares, 42,792 trades
Week starting 2026-03-09. Total ATS volume: 1,327,551 shares across 42,792 trades.
Mar 2, 2026
dark_pool
Dark Pool: WST — 1.1M shares, 39,876 trades
Week starting 2026-03-02. Total ATS volume: 1,108,526 shares across 39,876 trades.
Feb 24, 2026
short_interest
FTD: WST — 7,162 shares ($1.7M) failed to deliver
Settlement: 20260224, Price: $244.22, FTD Value: $1,749,103.64, WEST PHARMACEUTICAL SERV INC
Feb 23, 2026
dark_pool
Dark Pool: WST — 0.9M shares, 38,356 trades
Week starting 2026-02-23. Total ATS volume: 946,811 shares across 38,356 trades.
Feb 16, 2026
dark_pool
Dark Pool: WST — 1.1M shares, 41,680 trades
Week starting 2026-02-16. Total ATS volume: 1,069,309 shares across 41,680 trades.
Feb 9, 2026
dark_pool
Dark Pool: WST — 2.4M shares, 69,960 trades
Week starting 2026-02-09. Total ATS volume: 2,428,785 shares across 69,960 trades.